Home > Insider Trading > Filing (0001213900-24-017449)

Filing Details

Accession Number:: 0001213900-24-017449
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-02-27 15:27:17
Reporting Period:: 2024-02-23

Accepted Time:: 2024-02-27 15:27:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1865861	Cactus Acquisition Corp. 1 Ltd	CCTS	Blank Checks (6770)	981598362

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1918110	Cactus Healthcare Management Lp	C/O Cactus Acquisition Corp. 1 Limited 4B Cedar Brook Drive Cranbury NJ 08512		No	No	Yes	No
1918130	Cactus Healthcare Management Llc	C/O Cactus Acquisition Corp. 1 Limited 4B Cedar Brook Drive Cranbury NJ 08512		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Ordinary Shares	Disposition	2024-02-23	2,530,000	$0.00	632,501	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Ordinary Shares	Warrants to purchase Class A ordinary shares	Disposition	2024-02-23	3,893,334	$0.00	3,893,334	$11.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
973,333			No	4	S	Direct

Footnotes

The transaction reported herein consists of the private sale by Cactus Healthcare Management LP of (i) 2,530,000 founders shares (consisting of 2,529,999 Class A ordinary shares and one Class B ordinary share which may be converted into a Class A ordinary share upon election by the holder thereof, and therefore treated for purposes hereof as a Class A ordinary share) and (ii) 3,893,334 warrants to purchase Class A ordinary shares.
The aggregate sales price received by the reporting persons for all securities sold in the transaction (the founders shares and the warrants) reported herein was $1.00, which is an effective price of less than $0.00 (i) per share and (ii) per warrant.
The securities reported in this row are held of record by Cactus Healthcare Management LP (the "Cactus sponsor"). Cactus Healthcare Management LLC (the "Cactus sponsor GP") serves as the sole general partner of the Cactus sponsor and directs voting and investment decisions made by the Cactus sponsor with respect to the subject shares. The Cactus sponsor GP is owned equally by Hibotan LLC (an affiliate of Israel Biotech Fund), Kalistcare Limited (an affiliate of Consensus Business Group) and Clal Biotechnology Industries Cactus Ltd. (an affiliate of Clal Biotechnology Industries Ltd.), each of which holds a 33.33% equity interest in the Cactus sponsor GP. The Cactus sponsor GP does not possess a pecuniary interest with respect to the subject shares and therefore disclaims beneficial ownership thereof.
The warrants become exercisable 30 days after the Issuer completes its initial business combination (which date is not known currently).
The warrants expire on the 5th year anniversary of the Issuer's initial business combination (which date is not known currently).